Orthofix Medical Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount
Orthofix Medical Inc. (OFIX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount of -$230.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-26.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization · last filed 2021-02-26
- Orthofix Medical Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2018 was -$230.00K.
- Orthofix Medical Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2017 was -$381.00K, a 125.80% decline from fiscal 2016.
- Orthofix Medical Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2016 was $1.48M, a 28.85% decline from fiscal 2015.
- Orthofix Medical Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2015 was $2.08M, a 18.46% decline from fiscal 2014.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 12 month as first filed |
|---|---|---|
| 2018-12-31 | -$230.00K 10-K · filed 2021-02-26 | $230.00K 10-K · filed 2019-02-25 |
| 2017-12-31 | -$381.00K 10-K · filed 2020-02-24 | $381.00K 10-K · filed 2018-02-26 |
| 2016-12-31 | $1.48M 10-K · filed 2019-02-25 | |
| 2015-12-31 | $2.08M 10-K · filed 2018-02-26 | -$2.08M 10-K · filed 2016-02-29 |
| 2014-12-31 | $2.55M 10-K · filed 2017-02-27 | -$2.55M 10-K · filed 2015-04-29 |
| 2013-12-31 | -$2.29M 10-K · filed 2016-02-29 | |
| 2012-12-31 | -$2.21M 10-K · filed 2015-04-29 | |
| 2011-12-31 | -$2.42M 10-K/A · filed 2015-03-31 | |
| 2010-12-31 | -$2.61M 10-K/A · filed 2014-03-24 | |
| 2009-12-31 | -$2.57M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |